APOE and Alzheimer disease: Increasing evidence suggests that the effect of APOE ε4 on AD risk is exerted through inhibition of amyloid-β (Aβ) clearance and promotion of Aβ aggregation (Liu et al., 2013; Yamazaki et al., 2019).